Four Mexican pharmaceutical companies have announced plans to invest more than 13 billion pesos in drug development and ...

In this Q&A, Dean discusses how RXO is helping brands optimize performance and build more resilient supply chains through technology and data-driven strategy.

The company joins a wave of global pharma companies reshoring operations to strengthen the US supply chain and meet patient ...

In the second part of this roundtable discussion, a panel of key opinion leaders dive into the key risk factors impacting the pharma manufacturing space, and how the industry should aim to address ...

Many popular proposals to reform the PBM industry are missing the forest for the trees, drug market experts said in ...

Many proposals to reform the PBM industry miss the forest for the trees, experts said this week. Instead, Congress should go ...

Labviva connects pharmaceutical R&D labs directly to 90% of all raw materials suppliers available in the United States and Europe.

Michael Halaiko and Alex Moylan, shareholders in the law firm of Baker Donelson, discuss the Trump Administration’s recent executive orders on domestic production of critical medicines.

The bill’s bipartisan supporters on Capitol Hill hope that a reduction in trade barriers with allies will increase access to ...